ALFEN N.V. EO -,10/ NL0012817175 /
24.06.2024 8:10:54 | Изменение -0.870 | Объем сделки | Бид15:45:12 | Предложение15:45:12 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
32.770EUR | -2.59% | 0 Оборот: 0.000 |
32.690Величина цены спроса: 280 | 32.880Величина цены предложения: 280 | 711.53 млнEUR | - | 23.91 |
GlobeNewswire
16:00
SPEE3D INTRODUCES NICKEL ALUMINIUM BRONZE (NAB EXPEDITIONARY) FOR COLD SPRAY ADDITIVE MANUFACTURING
GlobeNewswire
16:00
Ortoli Rosenstadt LLP Represents Siti B&T Group S.p.A and Its Shareholders in a Minority Investment ...
GlobeNewswire
16:00
Money Management International Congratulates 2024 Financial Literacy and Education in Communities (F...
GlobeNewswire
15:54
Court Approves $15 Million Settlement in U.S. Marshal Service Race Discrimination Class Action
GlobeNewswire
15:51
DEADLINE ALERT for CORBF, LNC, ADSK, and CMP: The Law Offices of Frank R. Cruz Reminds Investors of ...
GlobeNewswire
15:39
Greystone Provides $29 Million in HUD-Insured Financing for Skilled Nursing Facility in Tucson, Ariz...
Newsfile Corp
15:30
Oklahoma State University Earns Inaugural Carnegie Elective Classification for Leadership for Public...
GlobeNewswire
15:30
Trust Stamp announces an AI-powered solution for Deep Fake and other Injection Attacks
GlobeNewswire
15:30
TMT Acquisition Corp Merger Partner, eLong Power Holding Limited, Received RMB480 Million (Approxima...
GlobeNewswire
15:30
Verizon brings portable connectivity to sports and entertainment with new “Network in a Box”
GlobeNewswire
15:28
Red Lake Gaming Enterprises Inc. Selects Signature Systems Casino POS For Its Gaming Properties
GlobeNewswire
15:27
Ophthalmologists Favor Genentech’s Vabysmo and Regeneron’s Eylea HD for Diabetic Macular Edema Treat...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница